These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 15145454)

  • 1. Exploration of Moraxella catarrhalis outer membrane proteins, CD and UspA, as new carriers for lipooligosaccharide-based conjugates.
    Hu WG; Berry J; Chen J; Gu XX
    FEMS Immunol Med Microbiol; 2004 Jun; 41(2):109-15. PubMed ID: 15145454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and characterization of lipooligosaccharide-based conjugate vaccines for serotype B Moraxella catarrhalis.
    Yu S; Gu XX
    Infect Immun; 2005 May; 73(5):2790-6. PubMed ID: 15845482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of non-typeable Haemophilus influenzae outer membrane protein P6 as a new carrier for lipooligosaccharide conjugate vaccines.
    Wu T; Chen J; Murphy TF; Green BA; Gu XX
    Vaccine; 2005 Oct; 23(44):5177-85. PubMed ID: 16039021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological and immunological characteristics of lipooligosaccharide-based conjugate vaccines for serotype C Moraxella catarrhalis.
    Yu S; Gu XX
    Infect Immun; 2007 Jun; 75(6):2974-80. PubMed ID: 17371852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization with the truncated adhesin moraxella catarrhalis immunoglobulin D-binding protein (MID764-913) is protective against M. catarrhalis in a mouse model of pulmonary clearance.
    Forsgren A; Brant M; Riesbeck K
    J Infect Dis; 2004 Jul; 190(2):352-5. PubMed ID: 15216472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of LOS-specific antibody-secreting cells by ELISPOT assay].
    Jiao XA; Hirano T; Gu XX
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 May; 20(3):366-9. PubMed ID: 15193241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moraxella catarrhalis outer membrane protein CD elicits antibodies that inhibit CD binding to human mucin and enhance pulmonary clearance of M. catarrhalis in a mouse model.
    Liu DF; McMichael JC; Baker SM
    Infect Immun; 2007 Jun; 75(6):2818-25. PubMed ID: 17403868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of clearance of bacteria from murine lungs by immunization with detoxified lipooligosaccharide from Moraxella catarrhalis conjugated to proteins.
    Hu WG; Chen J; Battey JF; Gu XX
    Infect Immun; 2000 Sep; 68(9):4980-5. PubMed ID: 10948114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal vaccination with recombinant outer membrane protein CD and adamantylamide dipeptide as the mucosal adjuvant enhances pulmonary clearance of Moraxella catarrhalis in an experimental murine model.
    Becker PD; Bertot GM; Souss D; Ebensen T; Guzmán CA; Grinstein S
    Infect Immun; 2007 Apr; 75(4):1778-84. PubMed ID: 17101651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of nasal colonization of nontypeable Haemophilus influenzae following intranasal immunization with rLP4/rLP6/UspA2 proteins combined with aqueous formulation of RC529.
    Mason KW; Zhu D; Scheuer CA; McMichael JC; Zlotnick GW; Green BA
    Vaccine; 2004 Sep; 22(25-26):3449-56. PubMed ID: 15308371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological characterisation of truncated lipooligosaccharide-outer membrane protein based conjugate vaccine against Moraxella catarrhalis and nontypeable Haemophilus influenzae.
    Singh S; Wilson JC; Cripps AW; Massa H; Ozberk V; Grice ID; Peak IR
    Vaccine; 2020 Jan; 38(2):309-317. PubMed ID: 31668366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant lipooligosaccharide-based conjugate vaccine demonstrates a broad-spectrum effectiveness against Moraxella catarrhalis.
    Ren D; Yu S; Gao S; Peng D; Petralia RS; Muszynski A; Carlson RW; Robbins JB; Tsai CM; Lim DJ; Gu XX
    Vaccine; 2011 Jun; 29(25):4210-7. PubMed ID: 21501641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and characterization of lipooligosaccharide-based conjugates as vaccine candidates for Moraxella (Branhamella) catarrhalis.
    Gu XX; Chen J; Barenkamp SJ; Robbins JB; Tsai CM; Lim DJ; Battey J
    Infect Immun; 1998 May; 66(5):1891-7. PubMed ID: 9573066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outer membrane vesicles (OMVs) and detoxified lipooligosaccharide (dLOS) obtained from Brazilian prevalent N. meningitidis serogroup B strains protect mice against homologous and heterologous meningococcal infection and septic shock.
    Jessouroun E; da Silveira IF; Larangeira AP; Pereira S; Fernandes SA; Rabinovitch L; Frasch CE; Castro-Faria-Neto HC; Bozza PT
    Vaccine; 2004 Jun; 22(20):2617-25. PubMed ID: 15193387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal immunization of the combined lipooligosaccharide conjugates protects mice from the challenges with three serotypes of Moraxella catarrhalis.
    Ren D; Xie H; Zhang W; Hassan F; Petralia RS; Yu S; Lim DJ; Gu XX
    PLoS One; 2011; 6(12):e29553. PubMed ID: 22216312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moraxella catarrhalis bacterium without endotoxin, a potential vaccine candidate.
    Peng D; Hong W; Choudhury BP; Carlson RW; Gu XX
    Infect Immun; 2005 Nov; 73(11):7569-77. PubMed ID: 16239560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress toward the development of a vaccine to prevent Moraxella (Branhamella) catarrhalis infections.
    McMichael JC
    Microbes Infect; 2000 Apr; 2(5):561-8. PubMed ID: 10865201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific immune responses and enhancement of murine pulmonary clearance of Moraxella catarrhalis by intranasal immunization with a detoxified lipooligosaccharide conjugate vaccine.
    Jiao X; Hirano T; Hou Y; Gu XX
    Infect Immun; 2002 Nov; 70(11):5982-9. PubMed ID: 12379673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outer membrane proteins as a carrier for detoxified lipooligosaccharide conjugate vaccines for nontypeable Haemophilus influenzae.
    Wu TH; Gu XX
    Infect Immun; 1999 Oct; 67(10):5508-13. PubMed ID: 10496940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional characteristics of a protective monoclonal antibody against serotype A and C lipooligosaccharides from Moraxella catarrhalis.
    Hu WG; Chen J; McMichael JC; Gu XX
    Infect Immun; 2001 Mar; 69(3):1358-63. PubMed ID: 11179299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.